Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
http://www.pharmaceutical-technology.com/news/astrazeneca-to-acquire-neogene/
0
0
NHS expedites rollout of Bayer's darolutamide for prostate cancer - Pharmaceutical Technology
11/29/22 at 8:58am
Organization
Pharmaceutical Technology
Author
Vishnu Priyan
Details
34 words
Summarize
Health
Pharmaceuticals & Biotech
Bayer
NHS
Pharmaceutical Technology AstraZeneca
Neogene Therapeutics
AstraZeneca has signed an agreement for the acquisition of all outstanding equity of Neogene Therapeutics in a deal totalling up to $320m.
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...